Literature DB >> 2906116

Tissue-specific regulation of pyroglutamate aminopeptidase II activity by thyroid hormones.

G Ponce1, J L Charli, J A Pasten, C Aceves, P Joseph-Bravo.   

Abstract

Among the enzymes capable of degrading thyrotropin-releasing hormone (TRH) in vitro, two pyroglutamate aminopeptidases (PGA) are specific for TRH: thyroliberinase, a seric enzyme and PGAII, a membrane-bound peptidase. The effect of thyroid hormone status on the activity of these enzymes was evaluated in serum and various tissues. Only in adenohypophysis, triiodothyronine treatment increased PGAII to 376% of control; hypothyroidism produced the reverse effect (decrease to 23% of control). As previously reported, similar changes were observed for thyroliberinase. TRH degradation at the adenohypophysis level may participate in the negative feedback control of thyroid hormones.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2906116     DOI: 10.1159/000125011

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN: 0028-3835            Impact factor:   4.914


  8 in total

1.  The ups and downs of thyrotropin-releasing hormone.

Authors:  Kristen R Vella; Anthony N Hollenberg
Journal:  Endocrinology       Date:  2009-05       Impact factor: 4.736

2.  Regulation of adenohypophyseal pyroglutamyl aminopeptidase II activity by thyrotropin-releasing hormone and phorbol esters.

Authors:  M A Vargas; M Cisneros; P Joseph-Bravo; J L Charli
Journal:  Endocrine       Date:  2000-12       Impact factor: 3.633

Review 3.  Neuroregulation of ProTRH biosynthesis and processing.

Authors:  E A Nillni
Journal:  Endocrine       Date:  1999-06       Impact factor: 3.633

Review 4.  Multifactorial modulation of TRH metabolism.

Authors:  P Joseph-Bravo; R M Uribe; M A Vargas; L Pérez-Martínez; T Zoeller; J L Charli
Journal:  Cell Mol Neurobiol       Date:  1998-04       Impact factor: 5.046

5.  Tanycyte pyroglutamyl peptidase II contributes to regulation of the hypothalamic-pituitary-thyroid axis through glial-axonal associations in the median eminence.

Authors:  Edith Sánchez; Miguel Angel Vargas; Praful S Singru; Isel Pascual; Fidelia Romero; Csaba Fekete; Jean-Louis Charli; Ronald M Lechan
Journal:  Endocrinology       Date:  2009-01-29       Impact factor: 4.736

6.  Identification of the thyrotropin-releasing-hormone-degrading ectoenzyme as a metallopeptidase.

Authors:  G Czekay; K Bauer
Journal:  Biochem J       Date:  1993-03-15       Impact factor: 3.857

7.  Cloning of a cDNA encoding an ectoenzyme that degrades thyrotropin-releasing hormone.

Authors:  B Schauder; L Schomburg; J Köhrle; K Bauer
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-27       Impact factor: 11.205

8.  Intrauterine Zn Deficiency Favors Thyrotropin-Releasing Hormone-Increasing Effects on Thyrotropin Serum Levels and Induces Subclinical Hypothyroidism in Weaned Rats.

Authors:  Viridiana Alcántara-Alonso; Elena Alvarez-Salas; Gilberto Matamoros-Trejo; Patricia de Gortari
Journal:  Nutrients       Date:  2017-10-18       Impact factor: 5.717

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.